AddLife (STO:ALIF B) Seems To Use Debt Quite Sensibly
Jan 08
Have your own idea? Try our Stock Screener
Swedish (OMX) Life Sciences Industry Analysis
UpdatedJan 17, 2025
DataAggregated Company Financials
Companies11
- 7D-4.0%
- 3M-13.5%
- 1Y15.3%
- YTD-6.0%
Over the last 7 days, the Life Sciences industry has dropped 3.1%, driven by Biotage declining 15%. On the other hand AddLife is actually up 7.8%. In the past year, the industry has gained 15%. As for the next few years, earnings are expected to grow by 49% per annum.
Industry Valuation and Performance
Has the Swedish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 17 Jan 2025 | SEK 41.8b | SEK 16.7b | -SEK 1,152,911,426.00 | 43.4x | -36.3x | 2.5x |
| Sun, 15 Dec 2024 | SEK 44.1b | SEK 16.7b | -SEK 1,152,911,426.00 | 50.4x | -38.3x | 2.6x |
| Tue, 12 Nov 2024 | SEK 44.7b | SEK 16.8b | -SEK 948,072,426.00 | 50.9x | -47.1x | 2.7x |
| Thu, 10 Oct 2024 | SEK 47.1b | SEK 16.7b | -SEK 988,175,491.00 | 58.7x | -47.7x | 2.8x |
| Sat, 07 Sep 2024 | SEK 47.4b | SEK 16.7b | -SEK 988,176,492.00 | 59.9x | -48x | 2.8x |
| Mon, 05 Aug 2024 | SEK 47.4b | SEK 16.7b | -SEK 1,128,120,510.00 | 59.9x | -42x | 2.8x |
| Wed, 03 Jul 2024 | SEK 42.1b | SEK 16.3b | -SEK 1,188,686,510.00 | 54.3x | -35.4x | 2.6x |
| Fri, 31 May 2024 | SEK 42.3b | SEK 16.3b | -SEK 1,188,686,510.00 | 59.5x | -35.6x | 2.6x |
| Sun, 28 Apr 2024 | SEK 37.7b | SEK 16.2b | -SEK 1,246,589,705.00 | 36.2x | -30.2x | 2.3x |
| Tue, 26 Mar 2024 | SEK 39.7b | SEK 16.0b | -SEK 1,122,792,210.00 | 34.7x | -35.4x | 2.5x |
| Thu, 22 Feb 2024 | SEK 39.3b | SEK 16.2b | -SEK 1,117,407,350.00 | 43.4x | -35.2x | 2.4x |
| Sat, 20 Jan 2024 | SEK 35.8b | SEK 15.5b | -SEK 1,393,723,683.00 | 42.9x | -25.7x | 2.3x |
| Mon, 18 Dec 2023 | SEK 38.2b | SEK 15.5b | -SEK 1,393,723,683.00 | 47.6x | -27.4x | 2.5x |
| Wed, 15 Nov 2023 | SEK 32.6b | SEK 15.4b | -SEK 1,256,647,710.00 | 37.7x | -25.9x | 2.1x |
| Fri, 13 Oct 2023 | SEK 25.2b | SEK 15.1b | -SEK 1,134,516,711.00 | 35.7x | -22.2x | 1.7x |
| Sun, 10 Sep 2023 | SEK 29.2b | SEK 15.1b | -SEK 1,133,713,072.00 | 38.8x | -25.8x | 1.9x |
| Tue, 08 Aug 2023 | SEK 31.9b | SEK 15.1b | -SEK 213,871,038.00 | 46.3x | -149.2x | 2.1x |
| Thu, 06 Jul 2023 | SEK 36.6b | SEK 14.6b | -SEK 172,476,038.00 | 39x | -212.1x | 2.5x |
| Sat, 03 Jun 2023 | SEK 40.0b | SEK 14.6b | -SEK 173,602,038.00 | 39.5x | -230.2x | 2.7x |
| Mon, 01 May 2023 | SEK 36.4b | SEK 14.5b | -SEK 138,425,792.00 | 35x | -262.9x | 2.5x |
| Wed, 29 Mar 2023 | SEK 31.8b | SEK 14.6b | -SEK 57,185,459.00 | 31.1x | -556.2x | 2.2x |
| Fri, 24 Feb 2023 | SEK 38.4b | SEK 14.7b | -SEK 47,348,929.00 | 30.7x | -811.4x | 2.6x |
| Sun, 22 Jan 2023 | SEK 38.7b | SEK 14.2b | SEK 943.9m | 38.1x | 41x | 2.7x |
| Tue, 20 Dec 2022 | SEK 38.2b | SEK 14.1b | SEK 944.3m | 41.2x | 40.5x | 2.7x |
| Thu, 17 Nov 2022 | SEK 37.6b | SEK 14.1b | SEK 936.8m | 40.6x | 40.1x | 2.7x |
| Sat, 15 Oct 2022 | SEK 33.3b | SEK 13.5b | SEK 750.9m | 50x | 44.4x | 2.5x |
| Mon, 12 Sep 2022 | SEK 38.4b | SEK 13.5b | SEK 751.3m | 55.5x | 51.1x | 2.8x |
| Wed, 10 Aug 2022 | SEK 43.3b | SEK 13.2b | SEK 667.8m | 45.3x | 64.8x | 3.3x |
| Fri, 08 Jul 2022 | SEK 47.6b | SEK 13.2b | SEK 753.4m | 41.9x | 63.2x | 3.6x |
| Sun, 05 Jun 2022 | SEK 55.5b | SEK 13.2b | SEK 753.4m | 48.3x | 73.7x | 4.2x |
| Tue, 03 May 2022 | SEK 53.6b | SEK 12.7b | SEK 753.5m | 49.4x | 71.1x | 4.2x |
| Thu, 31 Mar 2022 | SEK 65.4b | SEK 11.8b | SEK 746.3m | 57.6x | 87.6x | 5.5x |
| Sat, 26 Feb 2022 | SEK 51.0b | SEK 11.9b | SEK 745.3m | 43x | 68.5x | 4.3x |
| Mon, 24 Jan 2022 | SEK 66.8b | SEK 10.8b | SEK 786.3m | 44.8x | 85x | 6.2x |
Price to Earnings Ratio
85x
Current Industry PE
- Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 2.9x is higher than the industry's current PS ratio of 2.5x.
Past Earnings Growth
- Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 16% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | 1.78% | |
| Healthcare | 0.50% | |
| Life Sciences | -3.99% | |
| Clinical Research and Equipment | -3.99% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALIF B AddLife | SEK 140.90 | 5.5% +SEK 889.6m | 35.6% | PE146.8x | |
| MAGLE Magle Chemoswed Holding | SEK 37.00 | -1.1% SEK 38.0m | 41.2% | PE43.4x | |
| GENO Genovis AB (publ.) | SEK 25.00 | 1.8% +SEK 29.5m | -50.0% | PE58.6x | |
| AROC AroCell | SEK 0.47 | 5.4% +SEK 5.5m | 12.2% | PS2.1x | |
| PEXA B PExA | SEK 0.25 | 27.8% +SEK 3.1m | -39.3% | PS18x |
